1977
DOI: 10.1185/03007997709110172
|View full text |Cite
|
Sign up to set email alerts
|

Imipramine, rheumatoid arthritis and rheumatoid factor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

1981
1981
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 12 publications
0
17
0
Order By: Relevance
“…Analgesic effects of antidepressant were usually detected after one week of treatment. Low doses of amitryptiline (10–30 mg daily) may be sufficient to provide an analgesic effect (Fowler et al, 1977; Hood et al, 2001; MacNeill and Dick, 1976; McQuay et al, 1992).…”
Section: Resultsmentioning
confidence: 99%
“…Analgesic effects of antidepressant were usually detected after one week of treatment. Low doses of amitryptiline (10–30 mg daily) may be sufficient to provide an analgesic effect (Fowler et al, 1977; Hood et al, 2001; MacNeill and Dick, 1976; McQuay et al, 1992).…”
Section: Resultsmentioning
confidence: 99%
“…Preliminary evidence suggests that subjective pain, observed pain behaviours, and grip strength may all be helped by such treatments. 43 …”
Section: Resultsmentioning
confidence: 99%
“…Ten studies have been published assessing the effects of antidepressant medications on pain control and/or depression severity among patients with RA. Medications examined included amitriptyline, 16-18 trimipramine, 19 imipramine, 20 milnacipran, 21 sertraline, 22 dotheipin, 23,24 and duloxetine 25 (Tables 1 and 2). Among these studies only 4 specifically targeted patients with RA and depression in the inclusion criteria, 17,19,22,23 seven assessed change in mental health outcome measures, 17-20,22-24 none accounted for diagnosis of comorbid fibromyalgia or neuropathy, and 1 assessed change in fibromyalgia symptom severity.…”
Section: Key Limitations Of Findings From Existing Studies As a Groupmentioning
confidence: 99%
“…Medications examined included amitriptyline, 16-18 trimipramine, 19 imipramine, 20 milnacipran, 21 sertraline, 22 dotheipin, 23,24 and duloxetine 25 (Tables 1 and 2). Among these studies only 4 specifically targeted patients with RA and depression in the inclusion criteria, 17,19,22,23 seven assessed change in mental health outcome measures, 17-20,22-24 none accounted for diagnosis of comorbid fibromyalgia or neuropathy, and 1 assessed change in fibromyalgia symptom severity. 21 Additionally, only 2 studies reported if patients were in disease remission or well controlled inflammation.…”
Section: Key Limitations Of Findings From Existing Studies As a Groupmentioning
confidence: 99%